Total Payments
$1,437
2024 Payments
$223.88
Companies
38
Transactions
66
Medicare Patients
6,037
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$1,437 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,437 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $179.33 | 4 | $0 (2023) |
| PFIZER INC. | $137.94 | 2 | $0 (2023) |
| Boston Scientific Corporation | $108.58 | 1 | $0 (2019) |
| GENZYME CORPORATION | $85.19 | 4 | $0 (2023) |
| Daiichi Sankyo Inc. | $79.39 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $55.42 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $47.43 | 3 | $0 (2019) |
| Amgen Inc. | $44.60 | 3 | $0 (2018) |
| Varian Medical Systems, Inc. | $42.37 | 2 | $0 (2018) |
| SOBI, INC | $39.93 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $223.88 | 11 | SOBI, INC ($39.93) |
| 2023 | $148.86 | 8 | Regeneron Healthcare Solutions, Inc. ($41.70) |
| 2022 | $200.02 | 11 | GENZYME CORPORATION ($44.31) |
| 2020 | $12.36 | 1 | Novartis Pharmaceuticals Corporation ($12.36) |
| 2019 | $345.76 | 10 | AstraZeneca Pharmaceuticals LP ($138.00) |
| 2018 | $260.55 | 10 | PFIZER INC. ($122.00) |
| 2017 | $245.27 | 15 | Daiichi Sankyo Inc. ($54.62) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Hematology/Oncology | ||||||
| 07/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: ONCOLOGY | ||||||
| 06/28/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Oncology | ||||||
| 06/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: ONCOLOGY | ||||||
| 06/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: ONCOLOGY | ||||||
| 05/31/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $21.30 | General |
| 05/03/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/23/2024 | Amneal Pharmaceuticals LLC | AVASTIN (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2023 | PFIZER INC. | IBRANCE (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2023 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Hematology | ||||||
| 08/11/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.04 | General |
| Category: Oncology | ||||||
| 07/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: ONCOLOGY | ||||||
| 05/20/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Oncology | ||||||
| 03/18/2023 | MorphoSys, US Inc. | MONJUVI (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Oncology | ||||||
| 01/07/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2022 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | Cash or cash equivalent | $21.30 | General |
| Category: Oncology | ||||||
| 10/05/2022 | Lilly USA, LLC | CYRAMZA (Drug), RETEVMO | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Oncology | ||||||
| 09/30/2022 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $20.16 | General |
| 08/31/2022 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,525 | 3,596 | $732,102 | $238,470 |
| 2022 | 21 | 1,356 | 3,528 | $682,226 | $227,004 |
| 2021 | 24 | 1,524 | 3,717 | $777,121 | $267,070 |
| 2020 | 23 | 1,632 | 4,167 | $856,625 | $289,339 |
Total Patients
6,037
Total Services
15,008
Medicare Billing
$1.0M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 164 | 396 | $160,776 | $60,101 | 37.4% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 208 | 1,320 | $142,560 | $46,324 | 32.5% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 87 | 87 | $65,250 | $28,164 | 43.2% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 89 | 89 | $53,400 | $15,801 | 29.6% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 116 | 122 | $64,050 | $15,762 | 24.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 109 | 109 | $37,605 | $15,068 | 40.1% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 118 | 421 | $42,942 | $10,904 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 146 | 212 | $28,440 | $10,585 | 37.2% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 113 | 221 | $42,903 | $10,445 | 24.3% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 30 | 30 | $21,030 | $5,368 | 25.5% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 78 | 251 | $13,858 | $3,942 | 28.4% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 36 | 40 | $10,200 | $2,551 | 25.0% |
| 77470 | Special radiation treatment | Facility | 2023 | 29 | 30 | $9,960 | $2,403 | 24.1% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2023 | 25 | 46 | $9,200 | $2,325 | 25.3% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Facility | 2023 | 26 | 26 | $5,486 | $2,109 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 23 | 25 | $3,735 | $1,909 | 51.1% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 50 | 58 | $6,728 | $1,749 | 26.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 44 | 55 | $4,365 | $1,374 | 31.5% |
| 77331 | Special radiation therapy planning | Facility | 2023 | 14 | 28 | $7,364 | $1,017 | 13.8% |
| 77332 | Design and construction of simple radiation treatment device | Facility | 2023 | 20 | 30 | $2,250 | $568.63 | 25.3% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 161 | 419 | $170,114 | $64,057 | 37.7% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 198 | 1,439 | $155,659 | $50,676 | 32.6% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 70 | 71 | $53,250 | $23,833 | 44.8% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2022 | 70 | 74 | $44,460 | $13,307 | 29.9% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 95 | 97 | $51,515 | $12,746 | 24.7% |
About Dr. Owen Thomas, MD
Dr. Owen Thomas, MD is a Radiation Oncology healthcare provider based in Rehoboth Beach, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1043412935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Owen Thomas, MD has received a total of $1,437 in payments from pharmaceutical and medical device companies, with $223.88 received in 2024. These payments were reported across 66 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($1,437).
As a Medicare-enrolled provider, Thomas has provided services to 6,037 Medicare beneficiaries, totaling 15,008 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Rehoboth Beach, DE
- Active Since 06/03/2007
- Last Updated 06/11/2021
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1043412935
Products in Payments
- CHANTIX (Drug) $122.00
- IMFINZI (Drug) $117.50
- GENERAL ONCOLOGY (Device) $108.58
- LIBTAYO (Biological) $78.41
- INJECTAFER (Drug) $54.62
- OPDIVO (Biological) $47.43
- JEVTANA (Drug) $44.66
- Kyprolis (Biological) $44.60
- DOPTELET (Drug) $39.93
- GILOTRIF (Drug) $32.43
- Lenvima (Drug) $30.33
- XTANDI (Drug) $30.12
- ENJAYMO (Biological) $29.66
- ELAHERE (Drug) $28.88
- MONJUVI (Drug) $28.35
- BrachyVision (Device) $28.24
- ADCETRIS (Biological) $27.97
- KEYTRUDA (Biological) $26.97
- Enhertu (Drug) $24.77
- CYRAMZA (Drug) $24.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.